- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-739X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Minimising treatment-associated risks in systemic cancer therapy ; volume:30 ; number:2 ; day:29 ; month:9 ; year:2007 ; pages:161-168 ; date:4.2008
Pharmacy world & science ; 30, Heft 2 (29.9.2007), 161-168, 4.2008
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11096-007-9157-4
- URN
-
urn:nbn:de:101:1-2021081019290982303546
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jaehde, Ulrich
- Liekweg, Andrea
- Simons, Sven
- Westfeld, Martina
- SpringerLink (Online service)
Other Objects (12)
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Oral Enzyme Therapy in Systemic Analgetic Treatment
Insurance and expanding systemic risks
Systemic risks in securities markets
Systemic Risks from Different Perspectives
Artificial intelligence, systemic risks, and sustainability
Emerging treatment modalities for systemic therapy in hepatocellular carcinoma
AI ethics and systemic risks in finance
Treatment with soluble CD24 attenuates COVID-19-associated systemic immunopathology
Adult systemic cat scratch disease associated with therapy for hepatitis C
New treatment paradigm with systemic therapy in intermediate-stage hepatocellular carcinoma
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis